{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:45:06Z","timestamp":1792626306918,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Hochschule Hannover (MHH)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Amino Acids"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>N<\/jats:italic>-Acetyl-L-cysteine (NAC) is an endogenous cysteine metabolite. The drug is widely used in chronic obstructive pulmonary disease (COPD) and as antidote in acetaminophen (paracetamol) intoxication. Currently, the utility of NAC is investigated in rheumatoid arthritis (RA), which is generally considered associated with inflammation and oxidative stress. Besides clinical laboratory parameters, the effects of NAC are evaluated by measuring in plasma or serum nitrite, nitrate or their sum (NOx) as measures of nitric oxide (NO) synthesis. Malondialdehyde (MDA) and relatives such as 4-hydroxy-nonenal and 15(<jats:italic>S<\/jats:italic>)-8-<jats:italic>iso<\/jats:italic>-prostaglandin F<jats:sub>2\u03b1<\/jats:sub> serve as measures of oxidative stress, notably lipid peroxidation. In this work, we review recent clinico-pharmacological studies on NAC in rheumatoid arthritis. We discuss analytical, pre-analytical and clinical issues and their potential impact on the studies outcome. Major issues include analytical inaccuracy due to interfering endogenous substances and artefactual formation of MDA and relatives during storage in long-term studies. Differences in the placebo and NAC groups at baseline with respect to these biomarkers are also a serious concern. Modern applied sciences are based on data generated using commercially available instrumental physico-chemical and immunological technologies and assays. The publication process of scientific work rarely undergoes rigorous peer\u00a0review of the analytical approaches used in the study in terms of accuracy\/trueness. There is pressing need of considering previously reported reference concentration ranges and intervals as well as specific critical issues such as artefactual formation of particular biomarkers during sample storage. The latter especially applies to surrogate biomarkers of oxidative stress, notably MDA and relatives. Reported data on NO, MDA and clinical parameters, including C-reactive protein, interleukins and tumour necrosis factor \u03b1, are contradictory in the literature. Furthermore, reported studies do not allow any valid conclusion about utility of NAC in RA. Administration of NAC patients with rheumatoid arthritis is not recommended in current European and American guidelines.<\/jats:p>","DOI":"10.1007\/s00726-022-03185-x","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T06:10:56Z","timestamp":1657692656000},"page":"1251-1260","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["N-Acetyl-L-cysteine in human rheumatoid arthritis and its effects on nitric oxide (NO) and malondialdehyde (MDA): analytical and clinical considerations"],"prefix":"10.1007","volume":"54","author":[{"given":"Dimitrios","family":"Tsikas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Mikuteit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,13]]},"reference":[{"issue":"5","key":"3185_CR1","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1046\/j.1365-2362.2001.00815.x","volume":"31","author":"G Anfossi","year":"2001","unstructured":"Anfossi G, Russo I, Massucco P, Mattiello L, Cavalot F, Trovati M (2001) N-acetyl-L-cysteine exerts direct anti-aggregating effect on human platelets. Eur J Clin Invest 31(5):452\u2013461. https:\/\/doi.org\/10.1046\/j.1365-2362.2001.00815.x","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"3185_CR2","doi-asserted-by":"publisher","first-page":"132","DOI":"10.2174\/1574887113666180307151937","volume":"13","author":"M Batooei","year":"2018","unstructured":"Batooei M, Tahamoli-Roudsari A, Basiri Z, Yasrebifar F, Shahdoust M, Eshraghi A, Mehrpooya M, Ataei S (2018) Evaluating the effect of oral N-acetylcysteine as an adjuvant treatment on clinical outcomes of patients with rheumatoid arthritis: a randomized, double blind clinical trial. Rev Recent Clin Trials 13(2):132\u2013138. https:\/\/doi.org\/10.2174\/1574887113666180307151937","journal-title":"Rev Recent Clin Trials"},{"issue":"1","key":"3185_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/00041552-199801000-00010","volume":"7","author":"C Baylis","year":"1998","unstructured":"Baylis C, Vallance P (1998) Curr Opin Nephrol Hypertens 7(1):59\u201362. https:\/\/doi.org\/10.1097\/00041552-199801000-00010","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"3185_CR4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/BF00606662","volume":"31","author":"L Borgstr\u00f6m","year":"1986","unstructured":"Borgstr\u00f6m L, Kagedal B, Paulsen O (1986) Pharmacokinetics of N-acetylcysteine in man. Eur J Clin Pharmacol 31:217\u2013222","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"3185_CR5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s40264-020-01026-y","volume":"44","author":"P Calverley","year":"2021","unstructured":"Calverley P, Rogliani P, Papi A (2021) Safety of N-acetylcysteine at high doses in chronic respiratory diseases: a review. Drug Saf 44(3):273\u2013290. https:\/\/doi.org\/10.1007\/s40264-020-01026-y","journal-title":"Drug Saf"},{"issue":"3","key":"3185_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3109\/03009748209098179","volume":"1","author":"S Colli","year":"1982","unstructured":"Colli S, Maderna P, Tremoli E, Colombo F, Canesi B (1982) Platelet function in rheumatoid arthritis. Scand J Rheumatol 1(3):139\u2013143. https:\/\/doi.org\/10.3109\/03009748209098179","journal-title":"Scand J Rheumatol"},{"key":"3185_CR7","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00726-022-03134-8","volume":"54","author":"K Esalatmanesh","year":"2022","unstructured":"Esalatmanesh K, Jamali A, Esalatmanesh R et al (2022) Effects of N-acetylcysteine supplementation on disease activity, oxidative stress, and inflammatory and metabolic parameters in rheumatoid arthritis patients: a randomized double-blind placebo-controlled trial. Amino Acids 54:433\u2013440. https:\/\/doi.org\/10.1007\/s00726-022-03134-8","journal-title":"Amino Acids"},{"key":"3185_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/ard.51.11.1219","author":"AJ Farrell","year":"1992","unstructured":"Farrell AJ, Blake DR, Palmer RM, Moncada S (1992) Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/ard.51.11.1219","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"3185_CR9","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/art.41752","volume":"73","author":"L Fraenkel","year":"2021","unstructured":"Fraenkel L, Bathon JM, England BR, St Clair EW, Arayssi T, Carandang K, Deane KD, Genovese M, Huston KK, Kerr G, Kremer J, Nakamura MC, Russell LA, Singh JA, Smith BJ, Sparks JA, Venkatachalam S, Weinblatt ME, Al-Gibbawi M, Baker JF, Barbour KE, Barton JL, Cappelli L, Chamseddine F, George M, Johnson SR, Kahale L, Karam BS, Khamis AM, Navarro-Mill\u00e1n I, Mirza R, Schwab P, Singh N, Turgunbaev M, Turner AS, Yaacoub S, Akl EA (2021) 2021 American college of rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol 73(7):1108\u20131123. https:\/\/doi.org\/10.1002\/art.41752","journal-title":"Arthritis Rheumatol"},{"issue":"9\u201310","key":"3185_CR10","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.lfs.2008.06.010","volume":"83","author":"A Ghasemi","year":"2008","unstructured":"Ghasemi A, Zahedi Asl S, Mehrabi Y, Saadat N, Azizi F (2008) Serum nitric oxide metabolite levels in a general healthy population: relation to sex and age. Life Sci 83(9\u201310):326\u2013331. https:\/\/doi.org\/10.1016\/j.lfs.2008.06.010","journal-title":"Life Sci"},{"issue":"1\u20132","key":"3185_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.clinbiochem.2009.09.011","volume":"43","author":"A Ghasemi","year":"2010","unstructured":"Ghasemi A, Zahediasl S, Azizi F (2010) Reference values for serum nitric oxide metabolites in an adult population. Clin Biochem 43(1\u20132):89\u201394. https:\/\/doi.org\/10.1016\/j.clinbiochem.2009.09.011","journal-title":"Clin Biochem"},{"issue":"4","key":"3185_CR12","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/FJC.0b013e3181b6e77b","volume":"54","author":"KR Gibson","year":"2009","unstructured":"Gibson KR, Neilson IL, Barrett F, Winterburn TJ, Sharma S, MacRury SM, Megson IL (2009) Evaluation of the antioxidant properties of N-acetylcysteine in human platelets: prerequisite for bioconversion to glutathione for antioxidant and antiplatelet activity. J Cardiovasc Pharmacol 54(4):319\u2013326. https:\/\/doi.org\/10.1097\/FJC.0b013e3181b6e77b","journal-title":"J Cardiovasc Pharmacol"},{"issue":"5\u20136","key":"3185_CR13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3109\/10408360903142326","volume":"46","author":"D Giustarini","year":"2009","unstructured":"Giustarini D, Dalle-Donne I, Tsikas D, Rossi R (2009) Oxidative stress and human diseases: origin, link, measurement, mechanisms, and biomarkers. Crit Rev Clin Lab Sci 46(5\u20136):241\u2013281","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"11","key":"3185_CR14","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.bcp.2012.09.010","volume":"84","author":"D Giustarini","year":"2012","unstructured":"Giustarini D, Milzani A, Dalle-Donne I, Tsikas D, Rossi R (2012) N-Acetylcysteine ethyl ester (NACET): a novel lipophilic cell-permeable cysteine derivative with an unusual pharmacokinetic feature and remarkable antioxidant potential. Biochem Pharmacol 84(11):1522\u20131533. https:\/\/doi.org\/10.1016\/j.bcp.2012.09.010","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"3185_CR15","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/0378-4347(94)00030-1","volume":"655","author":"M Guichardant","year":"1994","unstructured":"Guichardant M, Valette-Talbi L, Cavadini C, Crozier G, Berger M (1994) Malondialdehyde measurement in urine. J Chromatogr B Biomed Appl 655(1):112\u2013116. https:\/\/doi.org\/10.1016\/0378-4347(94)00030-1","journal-title":"J Chromatogr B Biomed Appl"},{"issue":"1","key":"3185_CR16","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/clinchem\/34.1.208","volume":"34","author":"C Hackett","year":"1988","unstructured":"Hackett C, Linley-Adams L, Walker V (1988) Plasma malondialdehyde: a poor measure of in vivo lipid peroxidation. Clin Chem 34(1):208","journal-title":"Clin Chem"},{"issue":"3","key":"3185_CR17","doi-asserted-by":"publisher","first-page":"246","DOI":"10.2174\/1573403X14666180926100811","volume":"15","author":"G Hashemi","year":"2019","unstructured":"Hashemi G, Mirjalili M, Basiri Z, Tahamoli-Roudsari A, Kheiripour N, Shahdoust M, Ranjbar A, Mehrpooya M, Ataei S (2019) A pilot study to evaluate the effects of oral N-acetyl cysteine on inflammatory and oxidative stress biomarkers in rheumatoid arthritis. Curr Rheumatol Rev 15(3):246\u2013253. https:\/\/doi.org\/10.2174\/1573403X14666180926100811","journal-title":"Curr Rheumatol Rev"},{"issue":"2","key":"3185_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2165\/00003088-199120020-00004","volume":"20","author":"MR Holdiness","year":"1991","unstructured":"Holdiness MR (1991) Clinical pharmacokinetics of N-acetylcysteine. Clin Pharmacokinet 20(2):123\u2013134. https:\/\/doi.org\/10.2165\/00003088-199120020-00004","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"3185_CR19","doi-asserted-by":"publisher","first-page":"574","DOI":"10.18502\/ijaai.v20i5.7407","volume":"20","author":"F Jamali","year":"2021","unstructured":"Jamali F, Ahmadzadeh A, Sahraei Z, Salamzadeh J (2021) Study of the effects of N-acetylcysteine on inflammatory biomarkers and disease activity score in patients with rheumatoid arthritis. Iran J Allergy Asthma Immunol 20(5):574\u2013583. https:\/\/doi.org\/10.18502\/ijaai.v20i5.7407","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"9","key":"3185_CR20","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/s0891-5849(97)00459-0","volume":"24","author":"D Jang","year":"1998","unstructured":"Jang D, Murrell GA (1998) Nitric oxide in arthritis. Free Radic Biol Med 24(9):1511\u20131519. https:\/\/doi.org\/10.1016\/s0891-5849(97)00459-0","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"3185_CR21","first-page":"363","volume":"4","author":"H Jonsson","year":"1986","unstructured":"Jonsson H, Wollheim FA, Svensson B (1986) No effect of acetylcystein on refractory rheumatoid arthritis. Clin Exp Rheumatol 4(4):363\u2013364","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"3185_CR22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13018-020-01595-9","volume":"15","author":"T Kanai","year":"2020","unstructured":"Kanai T, Kondo N, Okada M, Sano H, Okumura G, Kijima Y, Ogose A, Kawashima H, Endo N (2020) The JNK pathway represents a novel target in the treatment of rheumatoid arthritis through the suppression of MMP-3. J Orthop Surg Res 15(1):87. https:\/\/doi.org\/10.1186\/s13018-020-01595-9","journal-title":"J Orthop Surg Res"},{"issue":"3","key":"3185_CR23","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.ijcard.2014.07.296","volume":"176","author":"AA Kayacelebi","year":"2014","unstructured":"Kayacelebi AA, Pham VV, Willers J, Hahn A, Stichtenoth DO, Jordan J, Tsikas D (2014) Plasma homoarginine (hArg) and asymmetric dimethylarginine (ADMA) in patients with rheumatoid arthritis: is homoarginine a cardiovascular corrective in rheumatoid arthritis, an anti-ADMA? Int J Cardiol 176(3):1129\u20131131. https:\/\/doi.org\/10.1016\/j.ijcard.2014.07.296","journal-title":"Int J Cardiol"},{"issue":"18","key":"3185_CR24","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1517\/14656560802591430","volume":"9","author":"C Kelly","year":"2008","unstructured":"Kelly C, Saravanan V (2008) Treatment strategies for a rheumatoid arthritis patient with interstitial lung disease. Expert Opin Pharmacother 9(18):3221\u20133230. https:\/\/doi.org\/10.1517\/14656560802591430","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"3185_CR25","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3390\/biom11050655","volume":"11","author":"A Kobroob","year":"2021","unstructured":"Kobroob A, Peerapanyasut W, Kumfu S, Chattipakorn N, Wongmekiat O (2021) Effectiveness of N-acetylcysteine in the treatment of renal deterioration caused by long-term exposure to bisphenol A. Biomolecules 11(5):655. https:\/\/doi.org\/10.3390\/biom11050655","journal-title":"Biomolecules"},{"issue":"9","key":"3185_CR26","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1002\/art.34502","volume":"64","author":"ZW Lai","year":"2012","unstructured":"Lai ZW, Hanczko R, Bonilla E, Caza TN, Clair B, Bartos A, Miklossy G, Jimah J, Doherty E, Tily H, Francis L, Garcia R, Dawood M, Yu J, Ramos I, Coman I, Faraone SV, Phillips PE, Perl A (2012) N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 64(9):2937\u20132946. https:\/\/doi.org\/10.1002\/art.34502","journal-title":"Arthritis Rheum"},{"key":"3185_CR27","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/S0006-291X(80)80090-8","volume":"95","author":"DM Lee","year":"1980","unstructured":"Lee DM (1980) Malondialdehyde formation in stored plasma. Biochem Biophys Res Commun 95:1663\u20131670","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"3185_CR28","first-page":"79","volume":"7","author":"Y Lin","year":"1994","unstructured":"Lin Y, Jamieson D (1994) Potential artifacts in TBARS measurement in tissues from animals treated with antioxidants. Biomed Environ Sci 7(1):79\u201384","journal-title":"Biomed Environ Sci"},{"issue":"12","key":"3185_CR29","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1016\/j.clinthera.2010.11.001","volume":"32","author":"YM Liu","year":"2010","unstructured":"Liu YM, Liu Y, Lu C, Jia JY, Liu GY, Weng LP, Wang JY, Li GX, Wang W, Li SJ, Yu C (2010) Relative bioavailability of generic and branded acetylcysteine effervescent tablets: a single-dose, open-label, randomized-sequence, two-period crossover study in fasting healthy Chinese male volunteers. Clin Ther 32(12):2097\u20132105. https:\/\/doi.org\/10.1016\/j.clinthera.2010.11.001","journal-title":"Clin Ther"},{"issue":"1","key":"3185_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0003-2697(90)90002-q","volume":"184","author":"JD Morrow","year":"1990","unstructured":"Morrow JD, Harris TM, Roberts LJ 2nd (1990) Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids. Anal Biochem 184(1):1\u201310. https:\/\/doi.org\/10.1016\/0003-2697(90)90002-q","journal-title":"Anal Biochem"},{"issue":"2","key":"3185_CR31","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95(2):351\u2013358. https:\/\/doi.org\/10.1016\/0003-2697(79)90738-3","journal-title":"Anal Biochem"},{"issue":"12","key":"3185_CR32","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1002\/art.40223","volume":"69","author":"A Perl","year":"2017","unstructured":"Perl A (2017) Metabolic control of immune system activation in rheumatic diseases. Arthritis Rheumatol 69(12):2259\u20132270. https:\/\/doi.org\/10.1002\/art.40223","journal-title":"Arthritis Rheumatol"},{"issue":"3\u20134","key":"3185_CR33","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.niox.2009.09.001","volume":"21","author":"VV Pham","year":"2009","unstructured":"Pham VV, Stichtenoth DO, Tsikas D (2009) Nitrite correlates with 3-nitrotyrosine but not with the F(2)-isoprostane 15(S)-8-iso-PGF(2alpha) in urine of rheumatic patients. Nitric Oxide 21(3\u20134):210\u2013215. https:\/\/doi.org\/10.1016\/j.niox.2009.09.001","journal-title":"Nitric Oxide"},{"issue":"6","key":"3185_CR34","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1136\/annrheumdis-2019-216655","volume":"79","author":"JS Smolen","year":"2020","unstructured":"Smolen JS, Landew\u00e9 RBM, Bijlsma JWJ, Burmester GR, Dougados M, Kerschbaumer A, McInnes IB, Sepriano A, van Vollenhoven RF, de Wit M, Aletaha D, Aringer M, Askling J, Balsa A, Boers M, den Broeder AA, Buch MH, Buttgereit F, Caporali R, Cardiel MH, De Cock D, Codreanu C, Cutolo M, Edwards CJ, van Eijk-Hustings Y, Emery P, Finckh A, Gossec L, Gottenberg JE, Hetland ML, Huizinga TWJ, Koloumas M, Li Z, Mariette X, M\u00fcller-Ladner U, Mysler EF, da Silva JAP, Po\u00f3r G, Pope JE, Rubbert-Roth A, Ruyssen-Witrand A, Saag KG, Strangfeld A, Takeuchi T, Voshaar M, Westhovens R, van der Heijde D (2020) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis 79(6):685\u2013699. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216655","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"3185_CR35","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/ki.1995.411","volume":"48","author":"T S\u00fct\u00f6","year":"1995","unstructured":"S\u00fct\u00f6 T, Losonczy G, Qiu C, Hill C, Samsell L, Ruby J, Charon N, Venuto R, Baylis C (1995) Acute changes in urinary excretion of nitrite + nitrate do not necessarily predict renal vascular NO production. Kidney Int 48(4):1272\u20131277. https:\/\/doi.org\/10.1038\/ki.1995.411","journal-title":"Kidney Int"},{"issue":"6","key":"3185_CR36","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3390\/antiox10060967","volume":"10","author":"MCDS Ten\u00f3rio","year":"2021","unstructured":"Ten\u00f3rio MCDS, Graciliano NG, Moura FA, Oliveira ACM, Goulart MOF (2021) N-acetylcysteine (NAC): impacts on human health. Antioxidants (Basel) 10(6):967. https:\/\/doi.org\/10.3390\/antiox10060967","journal-title":"Antioxidants (Basel)"},{"issue":"8","key":"3185_CR37","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1080\/10715760500053651","volume":"39","author":"D Tsikas","year":"2005","unstructured":"Tsikas D (2005) Methods of quantitative analysis of the nitric oxide metabolites nitrite and nitrate in human biological fluids. Free Radic Res 39(8):797\u2013815. https:\/\/doi.org\/10.1080\/10715760500053651","journal-title":"Free Radic Res"},{"issue":"1\u20132","key":"3185_CR38","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jchromb.2006.07.054","volume":"851","author":"D Tsikas","year":"2007","unstructured":"Tsikas D (2007) Analysis of nitrite and nitrate in biological fluids by assays based on the Griess reaction: appraisal of the Griess reaction in the L-arginine\/nitric oxide area of research. J Chromatogr B Analyt Technol Biomed Life Sci 851(1\u20132):51\u201370. https:\/\/doi.org\/10.1016\/j.jchromb.2006.07.054","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"2","key":"3185_CR39","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ab.2008.04.018","volume":"379","author":"D Tsikas","year":"2008","unstructured":"Tsikas D (2008) A critical review and discussion of analytical methods in the L-arginine\/nitric oxide area of basic and clinical research. Anal Biochem 379(2):139\u2013163. https:\/\/doi.org\/10.1016\/j.ab.2008.04.018","journal-title":"Anal Biochem"},{"key":"3185_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.niox.2015.01.001","volume":"45","author":"D Tsikas","year":"2015","unstructured":"Tsikas D (2015) Circulating and excretory nitrite and nitrate: their value as measures of nitric oxide synthesis, bioavailability and activity is inherently limited. Nitric Oxide 45:1\u20133. https:\/\/doi.org\/10.1016\/j.niox.2015.01.001","journal-title":"Nitric Oxide"},{"key":"3185_CR41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ab.2016.10.021","volume":"524","author":"D Tsikas","year":"2017","unstructured":"Tsikas D (2017) Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: analytical and biological challenges. Anal Biochem 524:13\u201330. https:\/\/doi.org\/10.1016\/j.ab.2016.10.021","journal-title":"Anal Biochem"},{"issue":"4","key":"3185_CR42","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00726-021-02950-8","volume":"53","author":"D Tsikas","year":"2021","unstructured":"Tsikas D (2021) Extra-platelet low-molecular-mass thiols mediate the inhibitory action of S-nitrosoalbumin on human platelet aggregation via S-transnitrosylation of the platelet surface. Amino Acids 53(4):563\u2013573. https:\/\/doi.org\/10.1007\/s00726-021-02950-8","journal-title":"Amino Acids"},{"key":"3185_CR43","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jchromb.2014.12.019","volume":"1019","author":"D Tsikas","year":"2016","unstructured":"Tsikas D, Suchy MT (2016) Protocols for the measurement of the F2-isoprostane, 15(S)-8-iso-prostaglandin F2alpha, in biological samples by GC-MS or GC-MS\/MS coupled with immunoaffinity column chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 1019:191\u2013201. https:\/\/doi.org\/10.1016\/j.jchromb.2014.12.019","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"1\u20132","key":"3185_CR44","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/s0378-4347(97)00670-1","volume":"708","author":"D Tsikas","year":"1998","unstructured":"Tsikas D, Sandmann J, Ikic M, Fauler J, Stichtenoth DO, Fr\u00f6lich JC (1998) Analysis of cysteine and N-acetylcysteine in human plasma by high-performance liquid chromatography at the basal state and after oral administration of N-acetylcysteine. J Chromatogr B Biomed Sci Appl 708(1\u20132):55\u201360. https:\/\/doi.org\/10.1016\/s0378-4347(97)00670-1","journal-title":"J Chromatogr B Biomed Sci Appl"},{"issue":"20","key":"3185_CR45","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.1016\/j.febslet.2012.09.001","volume":"586","author":"D Tsikas","year":"2012","unstructured":"Tsikas D, Suchy MT, Niemann J, Tossios P, Schneider Y, Rothmann S, Gutzki FM, Fr\u00f6lich JC, Stichtenoth DO (2012) Glutathione promotes prostaglandin H synthase (cyclooxygenase)-dependent formation of malondialdehyde and 15(S)-8-iso-prostaglandin F2\u03b1. FEBS Lett 586(20):3723\u20133730. https:\/\/doi.org\/10.1016\/j.febslet.2012.09.001","journal-title":"FEBS Lett"},{"issue":"1","key":"3185_CR46","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ijcard.2014.09.109","volume":"177","author":"D Tsikas","year":"2014","unstructured":"Tsikas D, Niemann J, Flentje M, Schwarz A, Tossios P (2014) N-Acetylcysteine (NAC) inhibits renal nitrite and nitrate reabsorption in healthy subjects and in patients undergoing cardiac surgery: risk of nitric oxide (NO) bioavailability loss by NAC? Int J Cardiol 177(1):30\u201333. https:\/\/doi.org\/10.1016\/j.ijcard.2014.09.109","journal-title":"Int J Cardiol"},{"key":"3185_CR47","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jchromb.2015.10.009","volume":"1019","author":"D Tsikas","year":"2016","unstructured":"Tsikas D, Rothmann S, Schneider JY, Suchy MT, Trettin A, Modun D, Stuke N, Maassen N, Fr\u00f6lich JC (2016) Development, validation and biomedical applications of stable-isotope dilution GC-MS and GC-MS\/MS techniques for circulating malondialdehyde (MDA) after pentafluorobenzyl bromide derivatization: MDA as a biomarker of oxidative stress and its relation to 15(S)-8-iso-prostaglandin F2\u03b1 and nitric oxide (NO). J Chromatogr B Analyt Technol Biomed Life Sci 1019:95\u2013111. https:\/\/doi.org\/10.1016\/j.jchromb.2015.10.009","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"1","key":"3185_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpha.2017.12.003","volume":"8","author":"D Tsikas","year":"2018","unstructured":"Tsikas D, Schwedhelm KS, Surdacki A, Giustarini D, Rossi R, Kukoc-Modun L, Kedia G, \u00dcckert S (2018a) S-Nitroso-N-acetyl-L-cysteine ethyl ester (SNACET) and N-acetyl-L-cysteine ethyl ester (NACET)-Cysteine-based drug candidates with unique pharmacological profiles for oral use as NO, H2S and GSH suppliers and as antioxidants: results and overview. J Pharm Anal 8(1):1\u20139. https:\/\/doi.org\/10.1016\/j.jpha.2017.12.003","journal-title":"J Pharm Anal"},{"issue":"7","key":"3185_CR49","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00726-018-2573-z","volume":"50","author":"D Tsikas","year":"2018","unstructured":"Tsikas D, Hanff E, Bollenbach A, Kruger R, Pham VV, Chobanyan-J\u00fcrgens K, Wedekind D, Arndt T, J\u00f6rns A, Berb\u00e9e JFP, Princen HMG, L\u00fccke T, Mariotti F, Huneau JF, \u00dcckert S, Fr\u00f6lich JC, Lenzen S (2018b) Results, meta-analysis and a first evaluation of UNOxR, the urinary nitrate-to-nitrite molar ratio, as a measure of nitrite reabsorption in experimental and clinical settings. Amino Acids 50(7):799\u2013821. https:\/\/doi.org\/10.1007\/s00726-018-2573-z","journal-title":"Amino Acids"},{"issue":"5","key":"3185_CR50","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/rheumatology\/29.5.404-b","volume":"29","author":"G Vreugdenhil","year":"1990","unstructured":"Vreugdenhil G, Swaak AJ (1990) Effects of oral N-acetylcysteine on gold levels in rheumatoid arthritis. Br J Rheumatol 29(5):404\u2013405. https:\/\/doi.org\/10.1093\/rheumatology\/29.5.404-b","journal-title":"Br J Rheumatol"},{"issue":"2","key":"3185_CR51","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/BOR.0000000000000687","volume":"32","author":"B Wyman","year":"2020","unstructured":"Wyman B, Perl A (2020) Metabolic pathways mediate pathogenesis and offer targets for treatment in rheumatic diseases. Curr Opin Rheumatol 32(2):184\u2013191. https:\/\/doi.org\/10.1097\/BOR.0000000000000687","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"3185_CR52","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1186\/s12891-020-03562-1","volume":"21","author":"YT Yeh","year":"2020","unstructured":"Yeh YT, Liang CC, Chang CL, Hsu CY, Li PC (2020) Increased risk of knee osteoarthritis in patients using oral N-acetylcysteine: a nationwide cohort study. BMC Musculoskelet Disord 21(1):531. https:\/\/doi.org\/10.1186\/s12891-020-03562-1","journal-title":"BMC Musculoskelet Disord"},{"issue":"2","key":"3185_CR53","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00726-015-2105-z","volume":"48","author":"D Yi","year":"2016","unstructured":"Yi D, Hou Y, Wang L, Long M, Hu S, Mei H, Yan L, Hu CA, Wu G (2016) N-Acetylcysteine stimulates protein synthesis in enterocytes independently of glutathione synthesis. Amino Acids 48(2):523\u2013533. https:\/\/doi.org\/10.1007\/s00726-015-2105-z","journal-title":"Amino Acids"},{"issue":"45","key":"3185_CR54","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013087","volume":"97","author":"Q Zhang","year":"2018","unstructured":"Zhang Q, Ju Y, Ma Y, Wang T (2018) N-acetylcysteine improves oxidative stress and inflammatory response in patients with community acquired pneumonia: a randomized controlled trial. Medicine (baltimore) 97(45):e13087. https:\/\/doi.org\/10.1097\/MD.0000000000013087","journal-title":"Medicine (baltimore)"}],"container-title":["Amino Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-022-03185-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00726-022-03185-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-022-03185-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T02:13:53Z","timestamp":1660270433000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00726-022-03185-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,13]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["3185"],"URL":"https:\/\/doi.org\/10.1007\/s00726-022-03185-x","relation":{},"ISSN":["0939-4451","1438-2199"],"issn-type":[{"value":"0939-4451","type":"print"},{"value":"1438-2199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,13]]},"assertion":[{"value":"13 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study did not involve material from humans or animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}